Kelly Newman

Associate, New York

Biography

Overview

Kelly Newman is a litigation associate in the New York office. Ms. Newman's practice focuses on complex commercial litigation in the areas of antitrust, commercial contractual disputes and M&A-related litigation, representing clients in the pharmaceutical and financial services industries.

Ms. Newman also has experience representing pro bono clients in the area of criminal defense and has represented multiple clients in their appeals of convictions in New York state court.

During law school, Ms. Newman interned at the United States Attorney's Office in the District of Massachusetts and with the Honorable Gary S. Katzmann, Associate Justice of the Massachusetts Appeals Court. Ms. Newman also served on the editorial board of the Harvard Civil Rights—Civil Liberties Law Review.

Bars and Courts
New York State Bar
Education
JD
Harvard Law School
BA
Georgetown University
Languages
French
Russian

Experience

Member of trial team representing a global pharmaceutical company in a preliminary injunction hearing in the Southern District of New York in an antitrust action challenging a new product launch.

Representation of a major pharmaceutical company in defense of an antitrust class action alleging illegal reverse-payment settlements with generic pharmaceutical companies.

Representation of corporation in breach of contract action alleging breach of a letter of intent and seeking liquidated damages on the basis of breach of an exclusivity provision.

Representation of international bank in action alleging breach of a bankruptcy plan in which the tax benefits of the reorganized corporation’s net operating losses were to be distributed to creditors.

Representation of special committee of a corporation in shareholder class action alleging breach of fiduciary duties in the context of a merger agreement.

Awards and Recognition


Kelly Newman was named a "Litigator of the Week" by Global Competition Review for securing reversal of class certification in the Asacol® product-hopping litigation.